Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)
Colinz Laboratories Share Price
Colinz Labs share price insights
Company has spent less than 1% of its operating revenues towards interest expenses and 42.41% towards employee cost in the year ending 31 Mar, 2023. (Source: Standalone Financials)
Stock gave a 3 year return of 189.58% as compared to Nifty Smallcap 100 which gave a return of 87.46%. (as of last trading session)
Stock generated 189.58% return as compared to Nifty Pharma which gave investors 37.23% return over 3 year time period. (as of last trading session)
Colinz Laboratories Ltd. share price moved down by -3.40% from its previous close of Rs 44.01. Colinz Laboratories Ltd. stock last traded price is 42.51
Share Price Value Today/Current/Last 42.51 Previous Day 44.01
Key Metrics
PE Ratio (x) | - | ||||||||||
EPS - TTM (₹) | - | ||||||||||
MCap (₹ Cr.) | 11.09 | ||||||||||
Sectoral MCap Rank | 163 | ||||||||||
PB Ratio (x) | 1.27 | ||||||||||
Div Yield (%) | - | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| -0.12 | ||||||||||
VWAP (₹) | 42.58 | ||||||||||
52W H/L (₹) |
Colinz Labs Share Price Returns
1 Day | -3.4% |
1 Week | 0.71% |
1 Month | 6.94% |
3 Months | 3.81% |
1 Year | 11.43% |
3 Years | 189.58% |
5 Years | 553.0% |
Colinz Labs Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Peer Comparison
Colinz Labs Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 189.58% as compared to Nifty Smallcap 100 which gave a return of 87.46%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 189.58% return as compared to Nifty Pharma which gave investors 37.23% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 189.58% as compared to Nifty Smallcap 100 which gave a return of 87.46%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 189.58% return as compared to Nifty Pharma which gave investors 37.23% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Colinz Labs Board Meeting/AGM
Colinz Labs Dividends
- Others
Meeting Date Announced on Purpose Details May 29, 2024 May 06, 2024 Board Meeting Quarterly Results Jan 31, 2024 Jan 10, 2024 Board Meeting Quarterly Results Oct 31, 2023 Oct 16, 2023 Board Meeting Quarterly Results Sep 29, 2023 Jul 31, 2023 AGM A.G.M. Jul 31, 2023 Jul 14, 2023 Board Meeting Quarterly Results Dividend announcements are not available.
No other corporate actions details are available.
About Colinz Labs
Colinz Laboratories Ltd., incorporated in the year 1986, is a Small Cap company (having a market cap of Rs 11.09 Crore) operating in Pharmaceuticals sector. Colinz Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals for the year ending 31-Mar-2023. Show More
Executives
Auditors
- NK
N K Menon
Whole Time DirectorAKA Krishna Kumar
Independent DirectorVKVasant K Bhat
Independent DirectorMLMani L S
DirectorShow More - Sanjay R DholakiaVora & AssociatesS V Bhat & Co
Industry
Key Indices Listed on
-
Address
A-101, Pratik Ind.Estate,Mulund-Goregaon Link Road,Mumbai, Maharashtra - 400078
More Details
FAQs about Colinz Labs share
- 1. What is Colinz Labs share price and what are the returns for Colinz Labs share?Colinz Labs share price was Rs 42.51 as on 17 May, 2024, 03:31 PM IST. Colinz Labs share price was down by 3.40% based on previous share price of Rs 41.4. Colinz Labs share price trend:
- Last 1 Month: Colinz Labs share price moved up by 6.94%
- Last 3 Months: Colinz Labs share price moved up by 3.81%
- Last 12 Months: Colinz Labs share price moved up 11.43%
- Last 3 Years: Colinz Labs Share price moved up by 189.58%
- 2. What's the market capitalization of Colinz Labs?Within the Pharmaceuticals sector, Colinz Labs stock has a market cap rank of 163. Colinz Labs has a market cap of Rs 11.09 Cr.
- 3. Who are peers to compare Colinz Labs share price?Top 10 Peers for Colinz Labs are Norris Medicines Ltd., Kobo Biotech Ltd., Adline Chem Lab Ltd., Parmax Pharma Ltd., Chemo Pharma Laboratories Ltd., Brawn Biotech Ltd., Shyama Infosys Ltd., Unjha Formulations Ltd., Bacil Pharma Ltd. and MPS Pharma Ltd.
- 4. How can I quickly analyze Colinz Labs stock?Key Metrics for Colinz Labs are:
- PE Ratio of Colinz Labs is -
- Price/Sales ratio of Colinz Labs is 1.23
- Price to Book ratio of Colinz Labs is 1.27
- 5. What is Colinz Labs's 52 week high / low?Colinz Labs share price saw a 52 week high of Rs 50.00 and 52 week low of Rs 33.35.
- 6. Who's the owner of Colinz Labs?
- Promoter holding has not changed in last 9 months and holds 66.0 stake as on 31 Mar 2024
- Other investor holding has not changed in last 9 months and holds 34.0 stake as on 31 Mar 2024
- 7. Is the Colinz Labs profitable ?Total Revenue and Earning for Colinz Labs for the year ending 2023-03-31 was Rs 7.33 Cr and Rs 0.46 Cr on Standalone basis. Last Quarter 2023-12-31, Colinz Labs reported an income of Rs 1.76 Cr and profit of Rs 0.11 Cr.
Trending in Markets
Colinz Labs Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.